BACKGROUND: Although psychological sequelae are well known among survivors of childhood cancer, psychiatric sequelae remain inadequately explored. Long-term psychiatric sequelae and their main risk factors in this population were evaluated. PROCEDURE: Initially, 483 survivors of childhood cancer, except leukemia, were invited to complete a questionnaire assessing their health and quality of life. Of them, 130 completed the survey, subsequently consulted with a pediatric oncologist and an internist, and met with a psychologist for a semi-standardized interview based on the Mini International Neuropsychiatric Interview (MINI), which allowed diagnosis of DSM-IV Axis 1 psychiatric disorders. The collected data were compared with those of the French general population. RESULTS: Seventy-three of the 130 survivors (56.2%) who completed the MINI interview reported experiencing at least one psychiatric disorder since cancer diagnosis, mostly anxiety (39.2%), mood (27.7%), or major depressive (24.6%) disorders; 46 reported at least one current disorder (35.4%). Agoraphobia (P = 0.02) and psychotic disorders were more common (P = 0.003) and general anxiety disorder less common (P < 0.001) among survivors than the general population. Most disorders correlated significantly with survivors' ratings of lower quality of life. Smoking, cancer type, and treatments significantly influenced the prevalence of psychiatric disorders. CONCLUSIONS: Results were consistent between the self-questionnaire and MINI interview responses, though time may have biased memory. Vulnerability to and high risk for developing DSM-IV Axis 1 psychiatric disorders of childhood cancer survivors can persist long after diagnosis and treatment. Thus, systematic and general psychological screening of survivors may facilitate long-term psychological restoration.
BACKGROUND: Although psychological sequelae are well known among survivors of childhood cancer, psychiatric sequelae remain inadequately explored. Long-term psychiatric sequelae and their main risk factors in this population were evaluated. PROCEDURE: Initially, 483 survivors of childhood cancer, except leukemia, were invited to complete a questionnaire assessing their health and quality of life. Of them, 130 completed the survey, subsequently consulted with a pediatric oncologist and an internist, and met with a psychologist for a semi-standardized interview based on the Mini International Neuropsychiatric Interview (MINI), which allowed diagnosis of DSM-IV Axis 1 psychiatric disorders. The collected data were compared with those of the French general population. RESULTS: Seventy-three of the 130 survivors (56.2%) who completed the MINI interview reported experiencing at least one psychiatric disorder since cancer diagnosis, mostly anxiety (39.2%), mood (27.7%), or major depressive (24.6%) disorders; 46 reported at least one current disorder (35.4%). Agoraphobia (P = 0.02) and psychotic disorders were more common (P = 0.003) and general anxiety disorder less common (P < 0.001) among survivors than the general population. Most disorders correlated significantly with survivors' ratings of lower quality of life. Smoking, cancer type, and treatments significantly influenced the prevalence of psychiatric disorders. CONCLUSIONS: Results were consistent between the self-questionnaire and MINI interview responses, though time may have biased memory. Vulnerability to and high risk for developing DSM-IV Axis 1 psychiatric disorders of childhood cancer survivors can persist long after diagnosis and treatment. Thus, systematic and general psychological screening of survivors may facilitate long-term psychological restoration.
Authors: David R DeMaso; Johanna Calderon; George A Taylor; Jennifer E Holland; Christian Stopp; Matthew T White; David C Bellinger; Michael J Rivkin; David Wypij; Jane W Newburger Journal: Pediatrics Date: 2017-02-01 Impact factor: 7.124
Authors: Emily S Tonorezos; Jennifer S Ford; Linwei Wang; Kirsten K Ness; Yutaka Yasui; Wendy Leisenring; Charles A Sklar; Leslie L Robison; Kevin C Oeffinger; Paul C Nathan; Gregory T Armstrong; Kevin Krull; Lee W Jones Journal: Cancer Date: 2019-05-08 Impact factor: 6.921
Authors: Qianwei Liu; Therese Ml Andersson; Anna Jöud; Qing Shen; Maria Ec Schelin; Patrik Ke Magnusson; Karin E Smedby; Fang Fang Journal: Clin Epidemiol Date: 2019-12-02 Impact factor: 4.790
Authors: Michael Brinkers; Giselher Pfau; Anne-Marie Toepffer; Frank Meyer; Moritz A Kretzschmar Journal: Pain Res Manag Date: 2021-06-03 Impact factor: 3.037
Authors: Juliane Burghardt; Eva Klein; Elmar Brähler; Mareike Ernst; Astrid Schneider; Susan Eckerle; Marie Astrid Neu; Arthur Wingerter; Nicole Henninger; Marina Panova-Noeva; Jürgen Prochaska; Philipp Wild; Manfred Beutel; Jörg Faber Journal: Cancer Med Date: 2019-03-06 Impact factor: 4.452